Maximum quantity allowed is 999
请选择数量
CAS RN: 315-30-0 | 產品號碼: A0907
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| Solubility in 1mol/L NaOH | almost transparency |
| NMR | confirm to structure |
性質
| 熔點 | 384 °C |
| 水溶性 | Insoluble |
| Degree of solubility in water | 0.48 g/l 25 °C |
| 溶解性（不溶於） | Ethanol, Ether, Chloroform |
GHS
| 圖形表示 |
|
| 信號詞 | Danger |
| 危險性說明 | H301 : Toxic if swallowed. H317 : May cause an allergic skin reaction. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P272 : Contaminated work clothing should not be allowed out of the workplace. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P302 + P352 : IF ON SKIN: Wash with plenty of water. P362 + P364 : Take off contaminated clothing and wash it before reuse. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
| RTECS # | UR0785000 |
運輸資料
| UN編號 | UN2811 |
| 類別 | 6.1 |
| 包裝類別 | III |
| HS編碼* | 2933.59-000 |
Application
Allopurinol: A Purine Inhibitor of Xanthine Oxidase (XO)
Allopurinol is a xanthine oxidase (XO) inhibitor which inhibits the activity of xanthine oxidase, an enzyme involved in purine metabolism. XO catalyzes the oxidative hydroxylation of hypoxanthine [H0311] to xanthine [X0004] and further catalyze the oxidation of xanthine to uric acid [U0018]. Hence, XO inhibitors can lower serum levels of uric acid. In additon, febuxostat [F0847] is a non-purine inhibitor of XO. Allopurinol, first synthesized as a potential antitumor agent, is nowadays a clinical useful XO inhibitor used in the treatment of gout and the prevention of tumor lysis syndrome. (The product is for research purpose only.)
References
- Progress towards the discovery of xanthine oxidase inhibitors (a review)
- Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol (a review)
- Xanthine oxidase inhibition for chronic heart failure: Is allopurinol the next therapeutic advance in heart failure? (a review)
- A high-performance liquid chromatographic method for the determination of hypoxanthine, xanthine, uric acid and allantoin in serum
- Analysis of Purines in Urinary Calculi by High-Performance Liquid Chromatography
- A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection
考研文獻
文章/手冊
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。